BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1069546)

  • 1. Immunotherapy of human solid tumors with Bacillus Calmette-Guérin: prolongation of disease-free interval and survival in malignant melanoma, breast, and colorectal cancer.
    Gutterman JU; Mavligit GM; Blumenshein G; Burgess MA; McBride CM; Hersh EM
    Ann N Y Acad Sci; 1976; 277(00):135-59. PubMed ID: 1069546
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Large-bowel cancer-The current status of treatment.
    Carter SK
    J Natl Cancer Inst; 1976 Jan; 56(1):3-10. PubMed ID: 1255749
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemoimmunotherapy in disseminated melanoma and colorectal carcinoma.
    Gough IR; Bolton PM; Clunie GJ; Burnett W
    Aust N Z J Surg; 1978 Jun; 48(3):296-300. PubMed ID: 281221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer (Dukes' class C): prolongation of disease-free interval and survival.
    Mavligit GM; Gutterman JU; Malahy MA; Burgess MA; McBride CM; Jubert A; Hersh EM
    Cancer; 1977 Nov; 40(5 Suppl):2726-30. PubMed ID: 922710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunobiology of colorectal cancer.
    Mcdonald JS
    Semin Oncol; 1976 Dec; 3(4):421-31. PubMed ID: 793017
    [No Abstract]   [Full Text] [Related]  

  • 6. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
    Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of cancer: current status.
    Goodnight JE; Morton DL
    Prog Exp Tumor Res; 1980; 25():61-88. PubMed ID: 6986637
    [No Abstract]   [Full Text] [Related]  

  • 8. Surgical adjuvant immunotherapy for colorectal cancer.
    Enker WE; Jacobitz JL; Craft K; Wissler RW
    J Surg Oncol; 1978; 10(5):389-97. PubMed ID: 732327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer of the Dukes' C classification. Preliminary clinical results.
    Mavligit GM; Gutterman JU; Burgess MA; Khankhanian N; Seibert GB; Speer JF; Reed RC; Jubert AV; Martin RC; McBride CM; Copeland EM; Gehan EA; Hersh EM
    Cancer; 1975 Dec; 36(6 Suppl):2421-7. PubMed ID: 1212660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: Immunotherapy for colorectal cancer.
    Hsu LY; David K; Serotkin AV; Godmilov L; Hirschhorn K
    Lancet; 1976 Jun; 1(7973):1349-50. PubMed ID: 58334
    [No Abstract]   [Full Text] [Related]  

  • 11. Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer.
    Hoover HC; Surdyke MG; Dangel RB; Peters LC; Hanna MG
    Cancer; 1985 Mar; 55(6):1236-43. PubMed ID: 3882219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostimulation with intraperitoneally administered bacille Calmette Guérin for advanced malignant tumors of the gastrointestinal tract.
    Falk RE; MacGregor AB; Landi S; Ambus U; Langer B
    Surg Gynecol Obstet; 1976 Mar; 142(3):363-8. PubMed ID: 1251316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current protocol approaches in large bowel cancer.
    Carter SK
    Semin Oncol; 1976 Dec; 3(4):433-43. PubMed ID: 793018
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy from malignant disease.
    Goodnight JE; Morton DL
    Annu Rev Med; 1978; 29():231-83. PubMed ID: 348035
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized trial of adjuvant chemotherapy and immunotherapy in Stage I and Stage II cutaneous melanoma. An interim report.
    Sterchi JM; Wells HB; Case LD; Spurr CL; White DR; Richards F; Muss HB; Jackson DV; Stuart JJ; Cooper MR
    Cancer; 1985 Feb; 55(4):707-12. PubMed ID: 3967167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy in the treatment of colorectal cancers in the aged].
    Navarra S; Melita P; Di Mauro S
    Minerva Med; 1982 Apr; 73(18):1225-32. PubMed ID: 7078801
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant therapy in colorectal cancer. (A randomized trial comparing radio-chemotherapy and radio-chemotherapy combined with the methanol extraction residue of BCG, MER).
    Robinson E; Bartal A; Cohen Y; Milstein D; Mekori T
    Biomedicine; 1979 Feb; 31(1):8-10. PubMed ID: 383171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoimmunotherapy of human solid tumors.
    Gutterman JU; Mavligit GM; Hersh EM
    Med Clin North Am; 1976 May; 60(3):441-62. PubMed ID: 1063907
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of immunodeficiency induced by cancer chemotherapy with BCG].
    Miyata T; Masuda H; Inoue T; Saeki K; Torisu M
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):297-300. PubMed ID: 3341790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoimmunotherapy of metastatic large bowel cancer: nonspecific stimulation with BCG and levamisole.
    Valdivieso M; Bedikian A; Burgess MA; Rodriguez V; Hersh EM; Bodey GP; Mavligit GM
    Cancer; 1977 Nov; 40(5 Suppl):2731-9. PubMed ID: 336190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.